MC 148 gene therapy
Latest Information Update: 26 Apr 2002
At a glance
- Originator Nonindustrial source
- Class
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Transplant rejection
Most Recent Events
- 30 Jun 1999 New profile
- 30 Jun 1999 Preclinical development for Transplant rejection in USA (Injection)